Nevertheless, the variety of Ki-67 assays and lack of standardization has resulted in inconsistent inter-observer and inter-laboratory reproducibility, limiting the universal application of Ki-67 for prognostic and predictive evaluation in breast cancer in routine clinical practice [2,13]. This evidence concerns the gene MKI67 and breast cancer.